Royalty and Sublicense Income Reports Sample Clauses

Royalty and Sublicense Income Reports. Within sixty (60) days after the end of each Calendar Quarter, Licensee shall deliver to Penn a report (“License Fee Report”) setting out all details necessary to calculate the Royalty and the Penn Sublicense Income Share due under this Article 4 for such Calendar Quarter, including:
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Royalty and Sublicense Income Reports. Upon the first commercial sale of a Licensed Product anywhere in the world, Licensee shall submit quarterly reports to Rutgers on or before each January 31st, May 31st, August 31st and October 31st of each year. Each such report shall cover Licensee’s most recently completed calendar quarter, and will show: (a) the units and Net Sales of each type of Licensed Product sold by Licensee on which Running Royalties have not been paid, including a clear indication of how Net Sales were calculated; (b) the Sublicense Income earned by Licensee, (c) the Running Royalties and share of Sublicense Income, in U.S. dollars, payable hereunder, with a description of how such Running Royalties and Sublicense Income is allocated within the Rutgers Technology, to the extent allocable; (d) the method used to calculate the Running Royalties and Sublicense Income share payments; (e) the exchange rates used, if any; and (f) any other information relating to the foregoing reasonably requested by Rutgers. If no sales of Licensed Products have been made during any reporting period, and no Sublicense Income has been earned, Licensee shall provide a statement to this effect in writing to Rutgers in lieu of a report. Rutgers shall maintain the confidentiality of such reports in accordance with Article 20 of this Agreement.
Sample 1Sample 2

Related to Royalty and Sublicense Income Reports

  • Sublicense Income Company shall pay Medical School {***} of all Sublicense Income. Such amounts shall be due and payable within sixty (60) days after Company receives the relevant payment from the Sublicensee.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

  • PROGRESS AND ROYALTY REPORTS 8.1 For the period beginning [date] LICENSEE will submit to REGENTS a semi-annual progress report covering LICENSEE's activities related to the development and testing of all LICENSED PRODUCTS, LICENSED SERVICES and LICENSED METHOD and the obtaining of necessary governmental approvals, if any, for marketing in the United States. These progress reports will be made for all development activities until the first SALE occurs in the United States.

  • Royalty Licensee shall pay Licensor a royalty equal to the Royalty Rate times Net Sales.

  • Earned Royalty In addition to the annual license maintenance fee, ***** will pay Stanford earned royalties (Y%) on Net Sales as follows:

  • Sublicense Revenue In the event Licensee or an Affiliate of Licensee sublicenses under Section 2.2, Licensee shall pay CareFusion **THE CONFIDENTIAL PORTION HAS BEEN SO OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION.** of any Sublicense Revenues resulting from sublicense agreements executed by Licensee.

  • Royalty Reports After the first commercial sale of a Licensed Product anywhere in the world, LICENSEE shall submit to UNIVERSITY quarterly royalty reports on or before each February 28, May 31, August 31 and November 30 of each year. Each royalty report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar quarter and shall show:

  • Royalties 1. Royalties arising in a Contracting State and paid to a resident of the other Contracting State may be taxed in that other State.

  • Reports and Royalty Payments Within [* * *] days after the beginning of each Contract Quarter during the Royalty Term, Celgene shall deliver to Acceleron a report setting forth for the previous Contract Quarter the following information on a Licensed Product-by-Licensed Product and country-by-country basis in the Territory: (a) the gross sales and Net Sales of Licensed Product, (b) the number of units sold by Celgene, its Affiliates or Sublicensees, (c) the basis for any adjustments to the royalty payable for the sale of each Licensed Product, and (d) the royalty due hereunder for the sales of each Licensed Product (the “Royalty Report”). The total royalty due for the sale of Licensed Products during such Contract Quarter shall be remitted at the time such report is made. No such reports or royalty shall be due for any Licensed Product before the First Commercial Sale of such Licensed Product.

Time is Money Join Law Insider Premium to draft better contracts faster.